Scott Friedman describes Precision Medicine as “the right treatment or diagnostic for the right patient at the right time.” In this precís of his Paris NASH talk, he discusses the factors that shape Precision Medicine for hepatic function, including genetics, microbiome, human genome and CAR-T development. He concludes this opening discussion by focusing on stellate cells, starting with the history of stellate cell research and how they got their current name, and going on to discuss senescent, or aging, stellate cells, the “ultimate bad boys” of liver disease.
